Expanding network M3 Wake Research operates a premier, fully integrated clinical trial network with a growing nationwide footprint, presenting opportunities to offer sponsor programs access to a broad site portfolio and diverse patient recruitment.

Experience and scale With over 7,000 completed trials and a history dating back to 1984, the company demonstrates deep domain expertise and reliability, making it a compelling partner for sponsors seeking proven delivery, quality, and regulatory compliance.

Leadership expansion Recent executive additions and leadership appointments signal strategic growth in business development and operations, indicating heightened capacity for complex trials and broader sponsor engagement.

Acquisition momentum A pattern of acquisitions across specialties and regions enhances site diversity and therapeutic coverage, creating cross-sell opportunities for sponsors looking to consolidate trials under a single network.

Financial and tech readiness Mid to upper mid-market revenue band with a robust technology stack (CRM, ERP, analytics, and data protection tools) supports scalable trial management, enabling efficient onboarding, data flow, and sponsor reporting.